CareDx, Inc. is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers products, testing services, and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients.
The Senior Manager of Commercial Technology & CRM will lead strategic and operational initiatives across CareDx’s Commercial organization to ensure optimal field performance and alignment with corporate objectives. This role provides leadership for critical commercial technology projects with a focus on CRM oversight, systems integrations and data management. This person will lead the development and implementation of a fully integrated commercial enablement technology stack and work with business owners to translate needs into clear business requirements and prioritize commercial needs for IT projects. The ideal candidate is data-driven, highly fluent in latest commercial enablement technology options and a strong track record of cross-functional leadership.
Key Responsibilities:
Commercial Systems & Analytics
- Serve as project leader for a highly visible, cross-functional project to assess our current commercial enablement technology stack, design and build a fully integrated and scalable technology ecosystem that can best enable field sales, key customer team, customer/patient experience team and marketing.
- Design and implement tools to support sales productivity and promotional effectiveness.
- Collaborate on and implement data governance standards and ensure data quality across commercial systems.
- Develop and execute strategies to optimize field facing systems to maximize sales force effectiveness.
Strategic Insights & Planning
- Provide unbiased market intelligence to inform commercial strategy and planning.
- Identify critical business issues and growth opportunities, embedding an external market perspective into strategic decisions.
Reporting & Performance Management
- Develop tools and dashboards for real-time performance tracking and reporting.
- Ensure timely and accurate collection, analysis, and dissemination of field sales reports.
- Monitor department performance against KPIs and highlight areas of improvement.
- Other responsibilities as assigned.
Qualifications:
- Bachelor’s degree required; advanced degree (MBA, MEd, or life sciences) preferred.
- 6-8 years of experience in life science industry (pharmaceutical, biotech, med device or diagnostics).
- 3+ years of experience supporting field teams.
- Strong understanding of transplant medicine, diagnostic workflows, and healthcare provider dynamics.
- Proven expertise in commercial system implementation (CRM, data management, incentive compensation)
- Ability to translate complex data into actionable commercial strategy and tactics.
- Excellent communication, facilitation, and stakeholder engagement skills.
- Ability to self-direct projects and work with little supervision
Preferred Attributes:
- Experience in post-transplant diagnostics or related therapeutic areas (e.g., nephrology, rare disease, immunology, cardiology, pulmonology, hematology).
- Collaborative, proactive, and passionate about improving patient care through education.
- Certification in Salesforce Administration, Lean Six Sigma, or similar.
- Background in change management or process reengineering.
- Entrepreneurial spirit; comfortable with rapid change, resource constraints, and the need to be flexible about roles
Additional Details:
Every individual at CareDx has a direct impact on our collective mission to improve the lives of organ transplant patients worldwide. We believe in taking great care of our people, so they take even greater care of our patients.
Our competitive Total Rewards package for US Employees includes:
- Competitive base salary and incentive compensation
- Health and welfare benefits, including a gym reimbursement program
- 401(k) savings plan match
- Employee Stock Purchase Plan
- Pre-tax commuter benefits
- And more!
- Please refer to our page to view detailed benefits at https://caredx.com/company/careers
In addition, we have a Living Donor Employee Recovery Policy that allows up to 30 days of paid leave annually to a full-time employee who makes the selfless act of donating an organ or bone marrow.
With products that are making a difference in the lives of transplant patients today and a promising pipeline for the future, it’s an exciting time to be part of the CareDx team. Join us in partnering with transplant patients to transform our future together.
CareDx, Inc. is an Equal Opportunity Employer-vets/disabled, and participates in the E-Verify program.
By proceeding with our application and submitting your information, you acknowledge that you have read our U.S. Personnel Privacy Notice and consent to receive email communication from CareDx.
***We do not accept resumes from headhunters, placement agencies, or other suppliers that have not signed a formal agreement with us.***
Certain jurisdictions require notice of how we use and protect your personal information. For more information, please read our Privacy Policy
This is the anticipated base salary range for candidates who will work in Brisbane, California. The final salary offered to a successful candidate will be dependent on several factors that may include, but are not limited to, the type and length of experience within the job, the type and length of experience within the industry, education, etc. Base pay is one part of the Total Package that is provided to compensate and recognize employees for their work, and this role may be eligible for additional discretionary bonuses/incentives and restricted stock units. CareDx is a multi-state employer, and this salary range may not reflect positions that work in other states.
Similar Jobs
%20(1).png)
What We Do
CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions CareDx, Inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions. NASDAQ:CDNA About AlloSure® AlloSure is the first and only non-invasive blood test that directly measures allograft injury and identifies the probability of active rejection to better manage kidney transplant patients. AlloSure is a clinical-grade, proprietary Next-Generation Sequencing (NGS) based test to detect donor-derived cell-free DNA (dd-cfDNA) in order to identify organ injury in kidney transplant recipients. AlloSure is analytically validated as a sensitive, specific, and precise measurement of dd-cfDNA. AlloSure detects active rejection (acute active ABMR, chronic active ABMR, or TCMR) with high accuracy, outperforms serum creatinine in kidney transplant recipients, and is highly sensitive in distinguishing ABMR from no ABMR. AlloSure is performed in the CareDx CLIA-certified laboratory. http://www.allosure.com/ About AlloMap® AlloMap Molecular Expression Testing is a non-invasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. AlloMap testing measures the expression levels of 20 genes from a blood sample. The combined expression of these genes is represented as an AlloMap test score. AlloMap is performed in the CareDx CLIA-certified laboratory and has been commercially available in the United States since 2005. AlloMap was cleared by the U.S. Food and Drug Administration in 2008 and was CE marked for the European Union in 2011. Use of AlloMap is also included in the International Society for Heart and Lung Transplantation (ISHLT) Practice Guidelines, published in August 2010, the worldwide standard for the care of heart transplant patients. http://www.allomap.com/
